SEC Form 4 · accession 0001140361-18-007309
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian P McKeon
Officer — Executive VP & CFO
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2018 | M | 1,880 | $53.185 | A | 42,318 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right-to-buy)F2,F1 | $53.185 | Feb 9, 2018 | M | 1,880 | D | — | Dec 31, 2023 | Common Stock | 1,880 | 1,880 | D |
Explanation of responses
- F1This option vests in five equal annual installments, beginning on January 1, 2015. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
- F2Not applicable.